Lotze M, Olejniczak S, Skokos D
Nat Rev Immunol. 2024; 24(12):878-895.
PMID: 39054343
PMC: 11598642.
DOI: 10.1038/s41577-024-01061-1.
de Sousa Linhares A, Sharma S, Steinberger P, Leitner J
iScience. 2024; 27(3):109267.
PMID: 38455974
PMC: 10918215.
DOI: 10.1016/j.isci.2024.109267.
Holling G, Chavel C, Sharda A, Lieberman M, James C, Lightman S
Cell Mol Immunol. 2024; 21(3):260-274.
PMID: 38233562
PMC: 10902291.
DOI: 10.1038/s41423-024-01124-2.
Honikel M, Olejniczak S
Biomolecules. 2022; 12(9).
PMID: 36139142
PMC: 9496564.
DOI: 10.3390/biom12091303.
Feng G, Liang G, Zhang Y, Hu J, Zhou C, Li J
Genes (Basel). 2022; 13(7).
PMID: 35885926
PMC: 9317804.
DOI: 10.3390/genes13071143.
PDZ Proteins SCRIB and DLG1 Regulate Myeloma Cell Surface CD86 Expression, Growth, and Survival.
Moser-Katz T, Gavile C, Barwick B, Lee K, Boise L
Mol Cancer Res. 2022; 20(7):1122-1136.
PMID: 35380688
PMC: 9262820.
DOI: 10.1158/1541-7786.MCR-21-0681.
TRAF3 in T Cells Restrains Negative Regulators of LAT to Promote TCR/CD28 Signaling.
Arkee T, Hostager B, Houtman J, Bishop G
J Immunol. 2021; 207(1):322-332.
PMID: 34145060
PMC: 8683566.
DOI: 10.4049/jimmunol.2001220.
CD28 Costimulatory Domain-Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function.
Boucher J, Li G, Kotani H, Cabral M, Morrissey D, Lee S
Cancer Immunol Res. 2020; 9(1):62-74.
PMID: 33188139
PMC: 7864379.
DOI: 10.1158/2326-6066.CIR-20-0253.
Targeting Multiple Myeloma through the Biology of Long-Lived Plasma Cells.
Utley A, Lipchick B, Lee K, Nikiforov M
Cancers (Basel). 2020; 12(8).
PMID: 32751699
PMC: 7466116.
DOI: 10.3390/cancers12082117.
CD28 Deficiency Ameliorates Blast Exposure-Induced Lung Inflammation, Oxidative Stress, Apoptosis, and T Cell Accumulation in the Lungs via the PI3K/Akt/FoxO1 Signaling Pathway.
Liu Y, Tong C, Xu Y, Cong P, Liu Y, Shi L
Oxid Med Cell Longev. 2019; 2019:4848560.
PMID: 31565151
PMC: 6745179.
DOI: 10.1155/2019/4848560.
Survival of Long-Lived Plasma Cells (LLPC): Piecing Together the Puzzle.
Lightman S, Utley A, Lee K
Front Immunol. 2019; 10:965.
PMID: 31130955
PMC: 6510054.
DOI: 10.3389/fimmu.2019.00965.
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts.
Suryadevara C, Desai R, Farber S, Choi B, Swartz A, Shen S
Clin Cancer Res. 2018; 25(1):358-368.
PMID: 30425092
PMC: 6390292.
DOI: 10.1158/1078-0432.CCR-18-1211.
Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design.
Singh S, Jois S
Adv Protein Chem Struct Biol. 2018; 111:1-59.
PMID: 29459028
PMC: 6203451.
DOI: 10.1016/bs.apcsb.2017.08.003.
Burrowing through the Heterogeneity: Review of Mouse Models of PTCL-NOS.
Cutucache C, Herek T
Front Oncol. 2016; 6:206.
PMID: 27725924
PMC: 5035739.
DOI: 10.3389/fonc.2016.00206.
Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling.
Dobbins J, Gagnon E, Godec J, Pyrdol J, Vignali D, Sharpe A
Sci Signal. 2016; 9(438):ra75.
PMID: 27460989
PMC: 5929992.
DOI: 10.1126/scisignal.aaf0626.
CD28 Costimulation: From Mechanism to Therapy.
Esensten J, Helou Y, Chopra G, Weiss A, Bluestone J
Immunity. 2016; 44(5):973-88.
PMID: 27192564
PMC: 4932896.
DOI: 10.1016/j.immuni.2016.04.020.
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.
Long A, Haso W, Shern J, Wanhainen K, Murgai M, Ingaramo M
Nat Med. 2015; 21(6):581-90.
PMID: 25939063
PMC: 4458184.
DOI: 10.1038/nm.3838.
CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif.
Rozanski C, Utley A, Carlson L, Farren M, Murray M, Russell L
J Immunol. 2015; 194(10):4717-28.
PMID: 25833397
PMC: 4416738.
DOI: 10.4049/jimmunol.1402260.
In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation.
Morin S, Giroux V, Favre C, Bechah Y, Auphan-Anezin N, Roncagalli R
Cell Mol Life Sci. 2015; 72(14):2739-48.
PMID: 25725801
PMC: 4826669.
DOI: 10.1007/s00018-015-1873-7.
Factors regulating immunoglobulin production by normal and disease-associated plasma cells.
Jackson D, Elsawa S
Biomolecules. 2015; 5(1):20-40.
PMID: 25615546
PMC: 4384109.
DOI: 10.3390/biom5010020.